USPTO serial 79412372
INQUIQ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 15, 2026
- Examiner
- THINGVOLD, CALDER J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with INQUIQ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brent E Routman
Brent E Routman Merchant & Gould, P.C.150 South 5th Street, Suite 2200, P.O. BP.O. Box 2910Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific, research, measuring, detecting, and testing apparatus and instruments, namely, non-medical biosensors for measuring molecular binding, concentration, and interactions; Scientific analytical instruments in the nature of electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomolecules; Bioanalytical platforms comprised of computer hardware and recorded computer software for measuring the presence or absence, concentration, association, dissociation, affinity, binding rates, specificity and functional properties of biomolecules, namely chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, viruses, bacteria, antibodies, and antibody fragments; Molecular interaction analysis (MIA) systems comprised of computer hardware and recorded computer software for quantifying the affinity, kinetics, and thermodynamics of molecular binding, including protein-protein, protein-DNA, and antibody-antigen interactions, scientific laboratory research analyzers for measuring the binding rates of association and dissociation between molecules; Scientific laboratory research analyzers for measuring the strength of binding between molecules; Interaction analysis platforms comprised of computer hardware and recorded computer software for measuring, visualizing, and analyzing the physical binding or functional interactions between biomolecules; Biomolecular interaction analyzers for scientific laboratory use for measuring the binding of biomolecules; Scientific analytical laboratory epitope mapping instruments for measuring and identifying binding sites where antibodies interact with antigens; Competition assay platforms comprised of computer hardware and recorded computer software for measuring the binding affinity of biomolecules; Scientific laboratory research biophysical characterization instruments for measuring the physical, structural, and thermodynamic properties of biomolecules; Antibody characterization platforms comprised of computer hardware and recorded computer software for analyzing antibody specificity, affinity, kinetics and function; Hit validation platforms comprised of computer hardware and recorded computer software for evaluating binding affinity and kinetics and detecting false positives; Lead optimization tools in the nature of imaging apparatus and instruments for use in the study of proteins and peptides in drug development; Kinetics and affinity screening systems comprised of computer hardware and recorded computer software for measuring the strength and speed of molecular binding interactions; Quantitation instruments for laboratory scientific research use for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, dissociation, affinity, binding rates, specificity and functional properties of biomolecules, namely chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, viruses, bacteria, antibodies, and antibody fragments; fiber optic instruments in the nature of biosensors for scientific use for measuring molecular binding, concentration, and interactions; downloadable computer software for the control of biosensing instruments, to design, define and store the measurements to be executed by the instrument and to display, automatically process, and allow the user to process and store the measurement results; downloadable software for data acquisition and analysis; downloadable computer software for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, virus, bacteria, antibodies and antibody fragments; biosensors for scientific use, namely, label-free biosensors, optical biosensor, quantitative biosensors, evanescent field biosensors, optical waveguide biosensors, photonic integrated circuit biosensors, and refractive index biosensors all for measuring molecular binding, concentration, and interactions; biosensors for scientific use for analyzing chemical and biological samples for measuring the presence or absence, concentration, association, affinity, binding rates, specificity and functional properties of biomolecules, namely, chemical compounds, sugars, peptides, proteins, oligonucleotides, DNA, RNA, aptamers, cells, viruses, bacteria, antibodies and antibody fragments; fiber optic instruments in the nature of biosensors for scientific use in biomolecular measurement, quantification, kinetics, protein analysis, clinical research applications, drug development and nucleic acid interaction, antibody and antibody fragment characterization, protein-protein interactions, protein-peptide interactions, protein-DNA/RNA interactions, protein-lipid interactions, virus and vaccine research, protein-small molecule interactions; photonic integrated circuits | ACTIVE | — |
| 041 | Training services in the field of medicine; training for handling scientific instruments and apparatus for research in laboratories; training services in the field of photonic engineering and photonic chip spotting; training in the use of biosensors | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis, testing, in the field of biosensing and analysis of chemical and biological samples and research and design relating thereto; industrial analysis, industrial research and industrial design services in the field of biosensing and analysis of chemical and biological samples; quality control for others and authentication services in the field of chemical and biological samples; design and development of computer hardware and software; research and development in the field of bio-sensor technology; consultation in the field of bio-sensor technology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Delta Diagnostics B.V.
- Other trademarks owned by Delta Diagnostics B.V.
- Other trademarks owned by Delta Diagnostics B.V.
- Other trademarks in Class 009
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named INQUIQ
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 15, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 23, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 18, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 18, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 2, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Mar 2, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 2, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 21, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 21, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 19, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 19, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |